论文部分内容阅读
为探索减轻表阿霉素在临床应用中的毒副作用，自1996～1997年中应用以表阿霉素为主的化疗方案治疗恶性肿瘤69例，现将临床观察和体会报告如下：1临床资料近年来，较新型抗癌药物表阿霉素（EPI）已作为联合化疗中的一种重要药物，临床应用有明显的疗效。自1996年～1997年的临床
In order to explore the relief of the toxic and side effects of epirubicin in clinical applications, 69 cases of malignant tumors were treated with epirubicin-based chemotherapy from 1996 to 1997. Clinical observations and experiences are reported as follows: 1 Clinical data In recent years, the newer anti-cancer drug epirubicin (EPI) has been used as an important drug in combination chemotherapy, and has obvious clinical efficacy. Clinical from 1996 to 1997